← Open Payments lookup

ROSAURA RIOS: Open Payments

NPI 1649907569 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,961 in 67 payments from 14 companies in 2025. Trend: 2023 $862 · 2024 $1,084 · 2025 $1,961

Food & beverage: $1,961
CompanyPaymentsAmount
Dexcom, Inc.9$538
Novo Nordisk Inc20$239
Amgen Inc.7$229
Corcept Therapeutics8$184
Xeris Pharmaceuticals, Inc.6$177
Insulet Corporation2$144
Ascendis Pharma Endocrinology Inc3$144
Mannkind Corporation1$98
Bayer Healthcare Pharmaceuticals Inc.4$82
Boehringer Ingelheim Pharmaceuticals, Inc.2$37

Products named: Dexcom G6 Transmitter, Korlym, GVOKE HYPOPEN, Omnipod, Yorvipath, TEPEZZA, Wegovy, REPATHA.

Industry payments across TX — which companies pay providers there.